Literature DB >> 1516770

Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp.

G Slama, G Reach, M Cahane, C Quetin, F Villanove-Robin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516770     DOI: 10.1007/bf00401209

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  2 in total

1.  A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon.

Authors:  G Slama; C Alamowitch; N Desplanque; M Letanoux; P Zirinis
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

2.  Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.

Authors:  L Freychet; S W Rizkalla; N Desplanque; A Basdevant; P Zirinis; G Tchobroutsky; G Slama
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

  2 in total
  5 in total

1.  Severe hypoglycemia in insulin-dependent diabetic children treated by multiple injection insulin regimen.

Authors:  A Verrotti; F Chiarelli; A Blasetti; E Bruni; G Morgese
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 2.  Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.

Authors:  Antonio E Pontiroli
Journal:  J Diabetes Sci Technol       Date:  2014-11-10

3.  Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  E Stenninger; J Aman
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

4.  Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.

Authors:  Antonio E Pontiroli; Elena Tagliabue
Journal:  Acta Diabetol       Date:  2020-02-06       Impact factor: 4.280

5.  Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.

Authors:  Jennifer L Sherr; Katrina J Ruedy; Nicole C Foster; Claude A Piché; Hélène Dulude; Michael R Rickels; William V Tamborlane; Kathleen E Bethin; Linda A DiMeglio; Larry A Fox; R Paul Wadwa; Desmond A Schatz; Brandon M Nathan; Santica M Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W Beck
Journal:  Diabetes Care       Date:  2016-02-16       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.